These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31393316)

  • 1. Censoring for Loss to Follow-up in Time-to-event Analyses of Composite Outcomes or in the Presence of Competing Risks.
    Lesko CR; Edwards JK; Moore RD; Lau B
    Epidemiology; 2019 Nov; 30(6):817-824. PubMed ID: 31393316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When to Censor?
    Lesko CR; Edwards JK; Cole SR; Moore RD; Lau B
    Am J Epidemiol; 2018 Mar; 187(3):623-632. PubMed ID: 29020256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention?
    Johnson LF; Estill J; Keiser O; Cornell M; Moolla H; Schomaker M; Grimsrud A; Davies MA; Boulle A
    Am J Epidemiol; 2014 Dec; 180(12):1208-12. PubMed ID: 25399412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America.
    Chi BH; Yiannoutsos CT; Westfall AO; Newman JE; Zhou J; Cesar C; Brinkhof MW; Mwango A; Balestre E; Carriquiry G; Sirisanthana T; Mukumbi H; Martin JN; Grimsrud A; Bacon M; Thiebaut R;
    PLoS Med; 2011 Oct; 8(10):e1001111. PubMed ID: 22039357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term loss to follow-up in the TREAT Asia HIV Observational Database (TAHOD).
    Jiamsakul A; Kiertiburanakul S; Ng OT; Chaiwarith R; Wong W; Ditangco R; Nguyen KV; Avihingsanon A; Pujari S; Do CD; Lee MP; Ly PS; Yunihastuti E; Kumarasamy N; Kamarulzaman A; Tanuma J; Zhang F; Choi JY; Kantipong P; Sim B; Ross J; Law M; Merati TP;
    HIV Med; 2019 Aug; 20(7):439-449. PubMed ID: 30980495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for loss to follow-up, transfer or death among people living with HIV on their first antiretroviral therapy regimen in Mali.
    Baldé A; Lièvre L; Maiga AI; Diallo F; Maiga IA; Costagliola D; Abgrall S
    HIV Med; 2019 Jan; 20(1):47-53. PubMed ID: 30270487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gone But Not Lost: Implications for Estimating HIV Care Outcomes When Loss to Clinic Is Not Loss to Care.
    Edwards JK; Lesko CR; Herce ME; Murenzi G; Twizere C; Lelo P; Anastos K; Tymejczyk O; Yotebieng M; Nash D; Adedimeji A; Edmonds A
    Epidemiology; 2020 Jul; 31(4):570-577. PubMed ID: 32483067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias.
    Howe CJ; Cole SR; Chmiel JS; Muñoz A
    Am J Epidemiol; 2011 Mar; 173(5):569-77. PubMed ID: 21289029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss to follow-up and associated factors of patients in the National AIDS Program in Thailand.
    Teeraananchai S; Kerr SJ; Ruxrungtham K; Avihingsanon A; Chaivooth S; Teeraratkul A; Bhakeecheep S; Ongwandee S; Thanprasertsuk S; Law MG
    Antivir Ther; 2018; 23(6):529-538. PubMed ID: 29583122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss to Follow-up Trends in HIV-Positive Patients Receiving Antiretroviral Treatment in Asia From 2003 to 2013.
    De La Mata NL; Ly PS; Nguyen KV; Merati TP; Pham TT; Lee MP; Choi JY; Ross J; Law MG; Ng OT
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):555-562. PubMed ID: 28129256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of definitions of loss to follow-up (LTFU) in antiretroviral therapy program evaluation: variation in the definition can have an appreciable impact on estimated proportions of LTFU.
    Grimsrud AT; Cornell M; Egger M; Boulle A; Myer L
    J Clin Epidemiol; 2013 Sep; 66(9):1006-13. PubMed ID: 23774112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study.
    Mberi MN; Kuonza LR; Dube NM; Nattey C; Manda S; Summers R
    BMC Health Serv Res; 2015 Jul; 15():259. PubMed ID: 26141729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India.
    Nimkar S; Valvi C; Kadam D; Rewari BB; Kinikar A; Gupte N; Suryavanshi N; Deluca A; Shankar A; Golub J; Bollinger R; Gupta A; Marbaniang I; Mave V
    HIV Med; 2018 Jul; 19(6):395-402. PubMed ID: 29573312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation and Operational Research: Early Tracing of Children Lost to Follow-Up From Antiretroviral Treatment: True Outcomes and Future Risks.
    Ardura-Garcia C; Feldacker C; Tweya H; Chaweza T; Kalulu M; Phiri S; Wang D; Weigel R
    J Acquir Immune Defic Syndr; 2015 Dec; 70(5):e160-7. PubMed ID: 26218409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.